Evidence map›Paper›PMID 26693097›Full record

ArticleTranslational vision science & technology2015

Feasibility of Structural and Functional MRI Acquisition with Unpowered Implants in Argus II Retinal Prosthesis Patients: A Case Study.

Samantha I Cunningham, Yonggang Shi, James D Weiland, Paulo Falabella, Lisa C Olmos de Koo, David N Zacks, Bosco S Tjan

Abstract read
In one paragraph

Article in Translational vision science & technology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Structural evaluation in inherited retinal diseases.The British journal of ophthalmology · 2021
    Review
  6. Article
  7. Article
  8. Now is the Critical Time for Engineered Neuroplasticity.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2018
    Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Samantha I CunninghamDepartment of Biomedical Engineering, University of Southern California, Los Angeles, CA, USA.
Yonggang ShiLaboratory of Neuro Imaging, USC Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
James D WeilandUSC Eye Institute, University of Southern California, Los Angeles, CA, USA.
Paulo FalabellaUSC Eye Institute, University of Southern California, Los Angeles, CA, USA ; Department of Ophthalmology and Visual Sciences, Federal University of São Paulo, São Paulo, Brazil.
Lisa C Olmos de KooUSC Eye Institute, University of Southern California, Los Angeles, CA, USA.
David N ZacksKellogg Eye Center, University of Michigan, Ann Arbor, MI, USA.
Bosco S TjanNeuroscience Graduate Program, University of Southern California, Los Angeles, CA, USA ; Department of Psychology, University of Southern California, Los Angeles, CA, USA.

Funding

Mapping the Human Connectome: Structure, Function, and HeritabilityU54MH091657 · NIMH · WASHINGTON UNIVERSITY · PI UGURBIL, KAMIL, VAN ESSEN, DAVID C · 2010 to 2014
$34.7M
TR&D3: Intrinsic Surface MappingP41EB015922 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI VAN HORN, JOHN DARRELL · 2012 to 2022
$14.1M
Form Processing in Peripheral VisionR01EY017707 · NEI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI CHEN, NIHONG, CHUNG, SUSANA T · 2008 to 2018
$3.2M
Intrinsic Modeling and Tracking of Neuroanatomy in Alzheimer's DiseaseK01EB013633 · NIBIB · UNIVERSITY OF SOUTHERN CALIFORNIA · PI SHI, YONGGANG · 2012 to 2016
$833k
NEI NIH HHS R01 EY017707NIBIB NIH HHS K01 EB013633NIBIB NIH HHS P41 EB015922NIMH NIH HHS U54 MH091657
6 · The paper itself

Abstract

purposeMagnetic resonance imaging (MRI) can measure the effects of vision loss and recovery on brain function and structure. In this case study, we sought to determine the feasibility of acquiring anatomical and functional MRI data in recipients of the Argus II epiretinal prosthesis system.

methodsFollowing successful implantation with the Argus II device, two retinitis pigmentosa (RP) patients completed MRI scans with their implant unpowered to measure primary visual cortex (V1) functional responses to a tactile task, whole-brain morphometry, V1 cortical thickness, and diffusion properties of the optic tract and optic radiation. Measurements in the subjects with the Argus II implant were compared to measurements obtained previously from RP patients and sighted individuals.

resultsThe presence of the Argus II implant resulted in artifacts that were localized around the patient's implanted eye and did not extend into cortical regions or white matter tracts associated with the visual system. Structural data on V1 cortical thickness and the retinofugal tract obtained from the two Argus II subjects fell within the ranges of sighted and RP groups. When compared to the RP and sighted subjects, Argus II patients' tactile-evoked cross-modal functional MRI (fMRI) blood oxygen level-dependent (BOLD) responses in V1 also fell within the range of either sighted or RP groups, apparently depending on time since implantation.

conclusionsThis study demonstrates that successful acquisition and quantification of structural and functional MR images are feasible in the presence of the inactive implant and provides preliminary information on functional changes in the brain that may follow sight restoration treatments. TRANSITIONAL RELEVANCE: Successful MRI and fMRI acquisition in Argus II recipients demonstrates feasibility of using MRI to study the effect of retinal prosthesis use on brain structure and function.

Indexed as

dMRIfMRIMRIretinal prothesisretinitis pigmentosa

Identifiers

PMID26693097
PMCPMC4675319

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.